Dermata Therapeutics GAAP EPS of -$0.55 in-line
at seekingalpha.com (Tue, 10-Nov 5:31 PM)
DRMA jumps as Tome cosmetic study reports 71% seeing overall skin improvement after one treatment
Market Chameleon (Thu, 15-Oct 10:25 AM)
Dermata Sets Sights on August Launch of Tome™ as Strategic Pivot Drives Commercial Focus
Market Chameleon (Wed, 12-Aug 10:30 AM)
